"Biasanya kulit saya berminyak dan berjerawat, tapi sekarang sudah mulai mereda pas aku minum Astria," ujar Wulan Guritno. "Karena dengan menggunakan antioksidan, kulit saya tidak menjadi kering ...
BOSTON--(BUSINESS WIRE)--Astria Therapeutics, Inc. (NASDAQ:ATXS), a biopharmaceutical company focused on developing life-changing therapies for allergic and immunologic diseases, today announced ...
“2025 promises to be an exciting year for Astria, and we are building on the momentum from a successful 2024 with the initiation of two important clinical trials,” said Jill C. Milne, Ph.D ...
Oppenheimer boosted their price objective on shares of Astria Therapeutics from $26.00 to $28.00 and gave the stock an “outperform” rating in a research report on Thursday, November 14th.